• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲妥珠单抗和多柔比星序贯给药增加氧化应激和连接蛋白 43 丝氨酸 368 的磷酸化。

Trastuzumab and Doxorubicin Sequential Administration Increases Oxidative Stress and Phosphorylation of Connexin 43 on Ser368.

机构信息

Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy.

出版信息

Int J Mol Sci. 2022 Jun 7;23(12):6375. doi: 10.3390/ijms23126375.

DOI:10.3390/ijms23126375
PMID:35742818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224207/
Abstract

Human epidermal growth factor receptor-2 (HER2) is overexpressed in up to 30% of breast cancer cases, causing a more aggressive tumour growth and poor prognosis. Trastuzumab, the humanized antibody targeted to HER2, increased the life expectancy of patients, but severe cardiotoxicity emerged as a long-term adverse effect. Clinical evidence highlights that Trastuzumab-induced cardiotoxicity drastically increases in association with Doxorubicin; however, the exact mechanisms involved remain incompletely understood. In order to analyse the molecular mechanisms involved and the possible adaptative responses to Trastuzumab and Doxorubicin treatment, in this study, H9c2 cardiomyoblasts were used. Results showed that Trastuzumab and Doxorubicin sequential administration in cardiomyoblast increased cytosolic and mitochondrial ROS production, intracellular calcium dysregulation, mitochondrial membrane depolarization, and the consequent apoptosis, induced by both Trastuzumab and Doxorubicin alone. Furthermore, in these conditions, we observed increased levels of Connexin43 phosphorylated on Ser368 (pCx43). Since phosphorylation on Ser368 decreases gap junction intracellular communication, thus reducing the spread of death signals to adjacent cells, we hypothesized that the increase in pCx43 could be an adaptative response implemented by cells to defend neighbouring cells by Trastuzumab and Doxorubicin sequential administration. However, the other side of the coin is the resulting conduction abnormalities.

摘要

人表皮生长因子受体-2(HER2)在多达 30%的乳腺癌病例中过表达,导致肿瘤生长更具侵袭性和预后不良。曲妥珠单抗是一种针对 HER2 的人源化抗体,它延长了患者的预期寿命,但严重的心脏毒性也成为了一种长期的不良反应。临床证据表明,曲妥珠单抗引起的心脏毒性与多柔比星密切相关;然而,具体的相关机制仍不完全清楚。为了分析涉及的分子机制以及曲妥珠单抗和多柔比星治疗可能产生的适应性反应,本研究使用了 H9c2 心肌细胞。结果表明,曲妥珠单抗和多柔比星序贯给药会增加心肌细胞内的 ROS 生成、细胞内钙离子失衡、线粒体膜去极化以及随后的细胞凋亡,这些作用与曲妥珠单抗和多柔比星单独作用的效果相似。此外,在这些条件下,我们观察到磷酸化的 Connexin43(pCx43)水平增加。由于 Ser368 位点的磷酸化会降低缝隙连接的细胞内通讯,从而减少死亡信号向相邻细胞的扩散,我们假设 pCx43 的增加可能是细胞对曲妥珠单抗和多柔比星序贯给药的适应性反应,通过这种方式保护邻近细胞。然而,硬币的另一面是由此导致的传导异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/72ae34fc47cd/ijms-23-06375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/44d4cf570f20/ijms-23-06375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/f83219376de1/ijms-23-06375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/d1ba1c24a84f/ijms-23-06375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/2ef48f4c5ae3/ijms-23-06375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/72ae34fc47cd/ijms-23-06375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/44d4cf570f20/ijms-23-06375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/f83219376de1/ijms-23-06375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/d1ba1c24a84f/ijms-23-06375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/2ef48f4c5ae3/ijms-23-06375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/9224207/72ae34fc47cd/ijms-23-06375-g005.jpg

相似文献

1
Trastuzumab and Doxorubicin Sequential Administration Increases Oxidative Stress and Phosphorylation of Connexin 43 on Ser368.曲妥珠单抗和多柔比星序贯给药增加氧化应激和连接蛋白 43 丝氨酸 368 的磷酸化。
Int J Mol Sci. 2022 Jun 7;23(12):6375. doi: 10.3390/ijms23126375.
2
Trastuzumab-induced cardiotoxicity and role of mitochondrial connexin43 in the adaptive response.曲妥珠单抗致心肌毒性与线粒体连接蛋白 43 在适应性反应中的作用。
Toxicol In Vitro. 2020 Sep;67:104926. doi: 10.1016/j.tiv.2020.104926. Epub 2020 Jun 26.
3
Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity.辛伐他汀降低多柔比星诱导的心脏毒性:超越其抗氧化活性的作用。
Int J Mol Sci. 2023 Apr 20;24(8):7573. doi: 10.3390/ijms24087573.
4
An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity.多柔比星联合曲妥珠单抗诱导心脏毒性的分子机制研究进展。
Life Sci. 2021 Sep 1;280:119760. doi: 10.1016/j.lfs.2021.119760. Epub 2021 Jun 21.
5
Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies.用于HER2/neu过表达乳腺癌的蒽环类-曲妥珠单抗治疗方案:当前经验与未来策略。
Ann Oncol. 2008 Sep;19(9):1530-9. doi: 10.1093/annonc/mdn292. Epub 2008 May 13.
6
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.新辅助治疗HER2阳性乳腺癌中双重抗HER2治疗的心脏安全性
Oncologist. 2017 Jun;22(6):642-647. doi: 10.1634/theoncologist.2016-0406. Epub 2017 Mar 24.
7
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.赫敏:一项随机2期试验,比较MM - 302联合曲妥珠单抗与医生选择的化疗方案联合曲妥珠单抗,用于治疗既往接受过治疗、未使用过蒽环类药物、HER2阳性、局部晚期/转移性乳腺癌患者。
BMC Cancer. 2016 Jun 3;16:352. doi: 10.1186/s12885-016-2385-z.
8
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients.在乳腺癌患者 2 年随访期间,化疗诱导的心脏毒性的累积发生率。
Breast Cancer Res Treat. 2020 Jul;182(2):333-343. doi: 10.1007/s10549-020-05703-5. Epub 2020 May 28.
9
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.对于过度表达HER2的转移性乳腺癌,使用化疗加一种抗HER2单克隆抗体进行治疗。
N Engl J Med. 2001 Mar 15;344(11):783-92. doi: 10.1056/NEJM200103153441101.
10
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.多生物标志物的纵向变化与接受多柔比星、紫杉烷和曲妥珠单抗治疗的乳腺癌患者的心脏毒性相关。
Clin Chem. 2015 Sep;61(9):1164-72. doi: 10.1373/clinchem.2015.241232. Epub 2015 Jul 27.

引用本文的文献

1
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition.前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂英克西兰通过抑制NLRP3和髓样分化因子88(MyD88)途径减轻蒽环类药物和曲妥珠单抗序贯暴露诱导的心脏毒性。
Int J Mol Sci. 2025 Jul 10;26(14):6617. doi: 10.3390/ijms26146617.
2
Simvastatin Enhances the Cytotoxic Effects of Doxorubicin in a Mammary Adenocarcinoma Cell Model by Involving Connexin 43.辛伐他汀通过连接蛋白43增强阿霉素在乳腺腺癌细胞模型中的细胞毒性作用。
J Biochem Mol Toxicol. 2025 Mar;39(3):e70214. doi: 10.1002/jbt.70214.
3
Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis.

本文引用的文献

1
Anthracycline-Induced Atrial Structural and Electrical Remodeling Characterizes Early Cardiotoxicity and Contributes to Atrial Conductive Instability and Dysfunction.蒽环类药物诱导的心房结构和电重构特征性地表现为早期心脏毒性,并导致心房传导不稳定和功能障碍。
Antioxid Redox Signal. 2022 Jul;37(1-3):19-39. doi: 10.1089/ars.2021.0002. Epub 2022 May 4.
2
Diazoxide Needs Mitochondrial Connexin43 to Exert Its Cytoprotective Effect in a Cellular Model of CoCl-Induced Hypoxia.地佐辛需要线粒体连接蛋白 43 来发挥其在 CoCl 诱导缺氧细胞模型中的细胞保护作用。
Int J Mol Sci. 2021 Oct 27;22(21):11599. doi: 10.3390/ijms222111599.
3
An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity.
利用单细胞RNA测序分析剖析三阴性乳腺癌微环境并鉴定潜在治疗药物
J Pharm Anal. 2024 Aug;14(8):100975. doi: 10.1016/j.jpha.2024.100975. Epub 2024 Apr 2.
4
Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity.辛伐他汀降低多柔比星诱导的心脏毒性:超越其抗氧化活性的作用。
Int J Mol Sci. 2023 Apr 20;24(8):7573. doi: 10.3390/ijms24087573.
5
Vx-809, a CFTR Corrector, Acts through a General Mechanism of Protein Folding and on the Inflammatory Process.Vx-809,一种 CFTR 纠正剂,通过一种蛋白质折叠的通用机制和炎症过程发挥作用。
Int J Mol Sci. 2023 Feb 20;24(4):4252. doi: 10.3390/ijms24044252.
多柔比星联合曲妥珠单抗诱导心脏毒性的分子机制研究进展。
Life Sci. 2021 Sep 1;280:119760. doi: 10.1016/j.lfs.2021.119760. Epub 2021 Jun 21.
4
Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model.缝隙连接蛋白 43 和缝隙连接蛋白 26 参与帕纳替尼诱导的心肌病:在小鼠模型中的性别相关差异。
Int J Mol Sci. 2021 May 28;22(11):5815. doi: 10.3390/ijms22115815.
5
Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.心脏中的连接蛋白:调节、功能和心脏疾病中的作用。
Int J Mol Sci. 2021 Apr 23;22(9):4413. doi: 10.3390/ijms22094413.
6
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.蒽环类药物联合曲妥珠单抗诱导的心脏毒性模型中的结构和电生理变化
Front Physiol. 2021 Apr 7;12:658790. doi: 10.3389/fphys.2021.658790. eCollection 2021.
7
Uric acid preconditioning alleviated doxorubicin induced JNK activation and Cx43 phosphorylation associated cardiotoxicity via activation of AMPK-SHP2 signaling pathway.尿酸预处理通过激活AMPK-SHP2信号通路减轻阿霉素诱导的JNK激活和Cx43磷酸化相关的心脏毒性。
Ann Transl Med. 2020 Dec;8(23):1570. doi: 10.21037/atm-20-3105.
8
New insights into affinity proteins for HER2-targeted therapy: Beyond trastuzumab.深入了解 HER2 靶向治疗的亲和蛋白:超越曲妥珠单抗。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188448. doi: 10.1016/j.bbcan.2020.188448. Epub 2020 Oct 9.
9
Doxorubicin‑induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads.多柔比星诱导的氧化和硝化应激:线粒体连接蛋白 43 处于十字路口。
Int J Mol Med. 2020 Sep;46(3):1197-1209. doi: 10.3892/ijmm.2020.4669. Epub 2020 Jul 6.
10
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model.在新辅助治疗环境中联合使用 H 型转铁蛋白-阿霉素和曲妥珠单抗可提高疗效并预防 HER2+ 鼠乳腺癌模型的心脏毒性。
Sci Rep. 2020 Jul 10;10(1):11425. doi: 10.1038/s41598-020-68205-w.